SPRYD7 and colorectal carcinoma: Moreover, besides SPRYD7 overexpression in KM12SM cells in comparison to KM12C poorly metastatic cells observed by proteomics (Figure 1A), SPRYD7 showed higher protein expression levels in the highly metastatic SW620 cells in comparison to its corresponding isogenic non-metastatic pair SW480 CRC cells (Figure 1C).